Difference between revisions of "Category:ALK inhibitors"
Jump to navigation
Jump to search
(Created page with "A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).") |
m |
||
| Line 1: | Line 1: | ||
A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was [[Crizotinib (Xalkori)]]. | A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was [[Crizotinib (Xalkori)]]. | ||
| + | |||
| + | [[Category:Kinase inhibitors]] | ||
Revision as of 18:56, 14 November 2014
A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).
Pages in category "ALK inhibitors"
The following 9 pages are in this category, out of 9 total.